Cureus · 2025
Cutaneous Adverse Events Following COVID-19 Vaccination in Japan: A Questionnaire Survey.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Yamamura Yuto, Nakashima Chisa, Kagawa Nana, Aoyama Yumi, Yamamoto Akihisa, Kawahira Hisao, Kubota Yumiko, Nakajima Saeko, Nakahara Takeshi, Fuyuno Yoko, Tsuruta Daisuke, Matsumoto Ayaki, Matsuo Risa, Abe Riichiro, Yuki Akihiko, Takahashi Hayato, Takahashi Chiaki, Imafuku Shin'Ichi, Sato Emi, Fujiwara Susumu, Yasuda Masahito, Tada Yayoi, Hayashi Kotaro, Katoh Norito, Watanabe Daisuke, Otsuka Atsushi
Аннотация
We conducted a nationwide survey in Japan to clarify the clinical spectrum of these events. An initial questionnaire was sent to 126 dermatology facilities, and responses were obtained from 66 (52.4%). Among these responding facilities, the most commonly identified cutaneous adverse events after COVID-19 vaccination were urticaria (49 (74.2%)), delayed local reactions (37 (56.1%)), erythema multiforme (31 (47.0%)), and alopecia (30 (45.5%)). In the detailed survey, the primary adverse events were EM (19 (20.9%)), bullous pemphigoid (7 (7.7%)), and alopecia (6 (6.6%)). The mean latency from vaccination to onset was 13.1 days, and the mean duration of symptoms was 74.2 days. Although this study cannot establish a direct causal relationship between vaccination and adverse events, it highlights the need for dermatologists to recognize potential cutaneous reactions and provide appropriate care.